Kernel focuses on neuroscience, operating within the healthcare and technology sectors. The company's main offerings include proprietary neurotechnology used to build a portfolio of brain-based biomarkers, accelerate treatment discovery, improve patient outcomes, and transform neuro medicine. Kernel primarily serves the healthcare industry, specifically the neuro medicine sector. It was founded in 2016 and is based in Culver City, California.

Neuralink focuses on the development of brain-computer interfaces. The company's main product is a fully implantable brain-computer interface designed to restore autonomy to individuals with unmet medical needs, such as quadriplegia, by enabling them to control computers and mobile devices with their thoughts. It primarily serves the medical technology and neuroscience sectors. It was founded in 2016 and is based in Fremont, California.

Paradromics provides data-rate brain-computer interfaces (BCI). It aims to enable treatment options for neurodegenerative diseases and advanced neuroprosthetic limbs for those suffering from amputation and spinal cord injuries. The company was founded in 2015 and is based in Austin, Texas.

Blackrock Neurotech is a company focused on the development of neurotechnology, specifically in the field of implantable brain-computer interfaces. The company's main offerings include devices that restore function and independence to individuals with neurological disorders, enabling them to perform tasks such as eating, drinking, sending emails, and operating robotic arms using their thoughts. Blackrock Neurotech primarily serves the healthcare and research sectors, with a particular focus on neurological disorders and paralysis. It was founded in 2008 and is based in Salt Lake City, Utah.

Neurable develops brain-computer interface (BCI) technology. It uses electroencephalogram (EEG) activity and builds an intelligent layer between the brain and computers. It focuses on building hardware and devices to measure brain activity and provide actionable insights. The company was founded in 2016 and is based in Boston, Massachusetts. .

Synchron operates as a medical device company focusing on the development of minimally invasive neuromodulation technology solutions. It develops an endovascular brain-computer interface that can access every corner of the brain using the blood vessels. It offers Synchron’s switch device to help paralyzed people, such as those with amyotrophic lateral sclerosis (ALS), communicate by controlling computer cursors with their minds. The company was founded in 2016 and is based in Brooklyn, New York.